Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 261-684-6 | CAS number: 59272-84-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 18 Jan - 11 Feb 1984
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
- Remarks:
- positive control missing, substance purity not given
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 984
- Report date:
- 1984
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- adopted in 1992
- Deviations:
- yes
- Remarks:
- no reliablity check was performed
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The study was conducted prior to the current requirement in Regulation (EC) 1907/2006 to perform an LLNA study (OECD 429) as the preferred in vivo skin sensitisation study.
Test material
- Reference substance name:
- (carboxymethyl)dimethyl-3-[(1-oxotetradecyl)amino]propylammonium hydroxide
- EC Number:
- 261-684-6
- EC Name:
- (carboxymethyl)dimethyl-3-[(1-oxotetradecyl)amino]propylammonium hydroxide
- Cas Number:
- 59272-84-3
- Molecular formula:
- C21H42N2O3
- IUPAC Name:
- (carboxymethyl)dimethyl-3-[(1-oxotetradecyl)amino]propylammonium hydroxide
- Test material form:
- solid
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- not specified
- Remarks:
- albino
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Central Institute for the Breeding of Laboratory Animals TNO, Zeist, The Netherlands
- Weight at study initiation: males: 237 - 315 g; females: 235 - 295 g
- Housing: individual in suspended stainless steel cages, fitted with wire mesh floors and fronts
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 6 days
- Indication of any skin lesions: no
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23 ± 1
- Humidity (%): 40
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- propylene glycol
- Concentration / amount:
- 20%
- Day(s)/duration:
- 1
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: vaseline
- Concentration / amount:
- 10%
- Day(s)/duration:
- 48 hours
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
Challenge
- Route:
- epicutaneous, semiocclusive
- Vehicle:
- other: vaseline
- Concentration / amount:
- 5% or 1%
- Day(s)/duration:
- 24 hours
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- 20 animals (10 male and 10 female) for test group and 10 animals (5 male and 5 female) for control group
- Details on study design:
- RANGE FINDING TESTS: no data available
MAIN STUDY
A. INDUCTION EXPOSURE
Induction is effected in a two-stage operation consisting of, firstly, three pairs of intradermal injections made simultaneously and, secondly, one week later, a closed patch exposure performed over the injection sites. For this purpose an area of c. 24 cm² of dorsal skin in the shoulder region is clipped free of hair with electric clippers.
Intradermal injections:
Three pairs of intradermal injections are made in the clipped area.
The preparations injected into the skin of the test animals are the following:
- sites a(left) and a(right): Freund’s Complete Adjuvant (FCA)
- sites b(left) and b(right): a dilution of the test substance in a suitable carrier (propylene glycol)
- sites c(left) and c(right): a dilution of the test substance in a mixture of FCA and carrier (1:1).
The preparations injected into the skin of the control animals are the following:
- sites a(left) and a(right): FCA
- sites b(left) and b(right): carrier
- sites c(left) and c(right): a mixture of FCA and carrier (1:1).
Skin readings are made 24 h after the treatment.
Topical application:
One week after induction by the intradermal injections the same area of the skin of the animals is closely shaved again. The test animals are treated as follows:
A 2 x 4 cm patch of Whatman No 3 MM filter paper is loaded with the appropriate mixture of the test substance and carrier. The patch is placed over the sites of the intradermal injections and covered with a piece of PVC foil and a piece of Leukopor hypo-allergic paper bandage. This, in turn, is secured with a 7.5 cm wide Tensoplast bandage. The dressing is left in place for 48 h. The control animals are similarly treated with patches with carrier (vaseline) only.
Skin readings are made after removal of the patches.
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: 2 weeks after topical induction
- Exposure period: 24 hours
- Test groups: test substance
- Control group: test substance
- Site: left flank
- Concentrations: 5 or 1%
- Evaluation (hr after challenge): 24 and 48 hours - Positive control substance(s):
- not specified
Results and discussion
- Positive control results:
- no data available
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 5% at challenge
- No. with + reactions:
- 1
- Total no. in group:
- 9
- Clinical observations:
- 1 male with score 1 for erythema and edema, respectively
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 5% at challenge
- No. with + reactions:
- 0
- Total no. in group:
- 9
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 20% intradermal induction, 10% topical induction, 5% at challenge
- No. with + reactions:
- 2
- Total no. in group:
- 20
- Clinical observations:
- 1 male with edema score of 1 and one male with erythema and edema score 1
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 20% intradermal induction, 10% topical induction, 5% at challenge
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Group:
- positive control
- Remarks on result:
- not measured/tested
Any other information on results incl. tables
One control female died on Day 9 of the study because of a prolapse of the rectum. All other animals remained in good health during the experimental period.
The challenge treatment with a 1% dilution - a concentration which is one fifth of the non-irritant concentration - did not elicit any sensitisation reaction under the conditions of the test.
Applicant's summary and conclusion
- Interpretation of results:
- study cannot be used for classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.